An autonomous robotic system for blood collection achieved performance and safety comparable to manual phlebotomy while maintaining sample quality and patient comfort, according to a multicenter clinical trial.
The study, published in Clinical Chemistry, evaluated an autonomous robotic phlebotomy device in routine outpatient settings and found that laboratory results from robot-collected samples were equivalent to those obtained by trained phlebotomists. This is an important finding for clinical laboratories – indicating that automation can be introduced without compromising diagnostic accuracy.
In day-to-day use, the device achieved a first-stick success rate of 94.5 percent, consistent with typical performance reported for experienced staff. Importantly, success remained high in patients who are often more challenging to bleed, including those with difficult venous access, obesity, and older age.
From a safety perspective, adverse events were rare and mild, occurring in 0.6 percent of procedures. These included expected events such as vasovagal reactions and minor hematomas, suggesting that the device introduces no new safety concerns compared with standard practice.
For laboratories, one of the most relevant findings is the low rate of hemolysis – just 0.3 percent overall. Hemolysis is a leading cause of sample rejection and repeat testing, so its reduction has direct implications for workflow efficiency, turnaround times, and patient care. The study suggests that standardized, automated handling during blood collection may help minimize preanalytical variability.
Patient experience was also favorable. Most patients reported pain that was similar to or less than manual phlebotomy, and 82 percent indicated they would accept or prefer the robotic system for future blood draws. This may support adoption in high-throughput outpatient settings where patient satisfaction and turnaround are priorities.
Beyond individual procedures, the findings highlight potential system-level benefits. Workforce shortages and variability in phlebotomy skill are ongoing challenges in laboratory medicine. A reliable automated approach could help stabilize service delivery, improve consistency in the preanalytical phase, and reduce dependence on highly variable manual techniques.
Overall, the results suggest that robotic phlebotomy could be integrated into clinical workflows as a safe and effective alternative, with potential to improve both operational efficiency and the quality of diagnostic testing.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
